At The Immune Frontier, The Hardest Questions Are Commercial

 
• By David Wild
  
Immune System
The Immunome Is Slowly Becoming the Target for Many Diverse Conditions (Shutterstock)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from In Vivo